Little is known about matrix biochemistry and cell differentiation pat
terns in chondrogenic neoplasms. This is the first description of the
focal expression of collagen type X by neoplastic chondrocytes in situ
and its incorporation into the extracellular matrix of cartilaginous
tumors. This shows that neoplastic chondrocytes have the potential to
undergo the full program of cell differentiation, including hypertroph
y, comparable to their physiological counterparts in the growth plate.
However, only in benign osteochondromas was a zonal expression of typ
e X collagen found similar to that observed in the growth plate, where
the cells immediately above the ossification frontier are selectively
positive for type X collagen. In enchondromas and chondrosarcomas, th
e expression was randomly distributed within the tumors. Surprisingly,
in less differentiated chondrosarcomas with spindle-shaped cells and
non-cartilaginous extracellular matrix, exceptional expression of coll
agen type X was observed, which indicates potential uncoupling of coll
agen type X expression from the differentiated chondrocytic phenotype
in neoplastic chondrocytes in vivo.